PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma

Abstract High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation has significantly improved overall survival (OS) in primary central nervous system lymphoma (PCNSL). However, early identification of long-term survivors remains a challenge. Progression-free survival at 2...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Vanja Zeremski, Tobias R. Haage, Hanno M. Witte, Louisa Adolph, Sina A. Beer, Gerhard Behre, Benedikt Jacobs, Christoph Kahl, Chrysavgi Lalayanni, Jens Panse, Sotirios Papageorgiou, Marina P. Siakantaris, Jessica Schneider, Ulf Schnetzke, Alexander Schulz, Theodoros P. Vassilakopoulos, Jeanette Walter, Dimitrios Mougiakakos
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2025-04-01
Serie:	Journal of Hematology & Oncology
Soggetti:	Primary CNS lymphoma PFS24 Overall survival
Accesso online:	https://doi.org/10.1186/s13045-025-01700-7
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!